BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Embryo
,
Autoimmunity
,
Prozac
,
rs2300478
,
VEGFA
,
glucose metabolic process
,
Arthritis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
EZH2
(gene)
NextBio Summary
General Info
Body Atlas
Most Correlated Tissues
Hematopoietic stem cell of bone marrow
Granulocyte-macrophage progenitor cell of bone marrow
T Lymphocyte (regulatory) of peripheral blood
Dendritic (plasmacytoid) cell
Testes
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Toxoplasmosis
Disease due to Orthopoxvirus
Injury of lung
Listeriosis
Disease due to Lentivirus
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Herceptin
Nonoxynol-9
Adenovirus E1A Proteins
PD 0332991
hen egg lysozyme
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Mir34c
L1TD1
PXDN
ZIC3
EZH2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Targeting EZH2 as cancer therapy.
A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesis.
Tumor-suppressive function of EZH2 is through inhibiting glutaminase.
The correlation of EZH2 expression with the progression and prognosis of hepatocellular carcinoma.
EZH2 and Endometrial Cancer Development: Insights from a Mouse Model.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia
A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negativ…
Study of Tazemetostat in Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma With…
EZH2 Inhibitor, Tazemetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer
Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ